Zobrazeno 1 - 10
of 45
pro vyhledávání: '"James J. Chamberlain"'
Publikováno v:
Clinical Diabetes : A Publication of the American Diabetes Association
The proliferation of smartphones over the past decade has led to the development of a seemingly endless number of digital applications (apps) designed to improve users’ health and fitness. This article addresses the regulation of these apps and pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8c8a6955b094b0665c8745fdf9fdaf
https://doi.org/10.2337/cd20-0046
https://doi.org/10.2337/cd20-0046
Autor:
James J. Chamberlain, Jennifer M. Trujillo, Jay H. Shubrook, Kacie Doyle-Delgado, Neil Skolnik
Publikováno v:
Annals of Internal Medicine. 173:813-821
Description The American Diabetes Association (ADA) updates the Standards of Medical Care in Diabetes annually to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56ceb7d345df5d32fbb888c3237e9b4
https://doi.org/10.7326/m20-2470
https://doi.org/10.7326/m20-2470
Autor:
Eric L. Johnson, Lacie Peterson, Andrew S. Rhinehart, James J. Chamberlain, Jay H. Shubrook, Sandra Leal
Publikováno v:
Annals of Internal Medicine. 168:640-650
The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273ae86fd044c32091fea304e4a0af71
https://doi.org/10.7326/m18-0222
https://doi.org/10.7326/m18-0222
Autor:
James J. Chamberlain
Publikováno v:
ADA Clinical Compendia. :8-10
Continuous glucose monitoring (CGM) systems fall into two categories: 1) “professional” (masked) CGM devices that patients wear without being able to see glucose values until their provider downloads and reviews the data retrospectively during an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e36d0e3fba426ff0b399804d510d6c5
https://doi.org/10.2337/db20181-8
https://doi.org/10.2337/db20181-8
Publikováno v:
Annals of internal medicine. 171(6)
The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8ba4d6008267d71a7ef617dcfb5d43
https://pubmed.ncbi.nlm.nih.gov/31404925
https://pubmed.ncbi.nlm.nih.gov/31404925
Autor:
Rita R. Kalyani, James J. Chamberlain, Sandra Leal, William H. Herman, Neil Skolnik, Andrew S. Rhinehart, Jay H. Shubrook
Publikováno v:
Annals of internal medicine. 166(8)
Description: The American Diabetes Association (ADA) annually updates the Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffeac0fe3f13f2cd4953bf8c491df54
https://pubmed.ncbi.nlm.nih.gov/28288484
https://pubmed.ncbi.nlm.nih.gov/28288484
Autor:
James J. Chamberlain, Emily Gilgen
Publikováno v:
Journal of Diabetes Science and Technology. 9:105-110
Background: We assessed the impact of perceived insulin pump usability on attitudes toward insulin pump therapy in diabetic individuals currently treated with multiple daily insulin injections (MDI). Method: This comparative, single-arm study recruit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7af69b757b7c0ba818f987b9a2989d
https://doi.org/10.1177/1932296814552822
https://doi.org/10.1177/1932296814552822
Autor:
James J. Chamberlain
Publikováno v:
ADA Clinical Compendia. :11-12
Identifying appropriate patients for continuous glucose monitoring (CGM) use is a vital component of therapy success. Potential candidates come from a diverse group of individuals with diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52be60a9222d92b6546b5d836f791b13
https://doi.org/10.2337/db20181-11
https://doi.org/10.2337/db20181-11
Publikováno v:
Clinical Diabetes. 31:106-109
IN BRIEF Realization of the clinical benefits of continuous glucose monitoring (CGM) in diabetes management is dependent on the frequency with which patients use their CGM devices. This article describes an eight-item survey used to explore whether p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb50eb5582841a88c7971f953fbf33b9
https://doi.org/10.2337/diaclin.31.3.106
https://doi.org/10.2337/diaclin.31.3.106
Publikováno v:
Journal of diabetes science and technology. 10(2)
We assessed the impact of "almost daily" use of continuous glucose monitoring (CGM) in adults with type 1 diabetes who had at least 1 year of CGM experience.In this single-center survey, we utilized a 16-item questionnaire to assess changes hypoglyce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d9eeea9a7125c4d0e0f69068221fe6c
https://pubmed.ncbi.nlm.nih.gov/26353781
https://pubmed.ncbi.nlm.nih.gov/26353781